Data / Form D filings / EpiVario Inc.
EpiVario Inc.: Form D filing
EpiVario Inc., a pharmaceuticals company in Philadelphia, PA, filed a Form D with the SEC in 2026. The latest, on October 13, 2026, reports $185,000 sold of a $500,000 offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3401 GRAYS FERRY AVENUE BUILDING 176, Philadelphia, PA, 19146
- Phone
- (215) 400-0133
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1753351
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13 | New notice | $500,000 | $185,000 | $315,000 | 9 | Sep 25 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas Kim | Executive Officer, Director | |
| Christopher Cashman | Director | |
| Eric Schultenover | Director |
Every Form D from the week of Oct 12 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what EpiVario Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.